Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease: Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2315-2323

  Walter, Michael ^a   Reinecke, Holger ^a   Gerdes, Ute ^a   Nofer, Jerzy Roch ^a   Höbbel, Gunnar ^a   Seedorf, Udo ^a   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

apolipoprotein A I; G proteins; lipoproteins, HDL; phosphatidylcholines; signal transduction

Indexed keywords

APOLIPOPROTEIN A1; BUTANOL; DIACYLGLYCEROL; ENDOTHELIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PERTUSSIS TOXIN; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROPRANOLOL; PROTEIN KINASE C;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME REGULATION; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TANGIER DISEASE;

EID: 0029852937     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119043     Document Type: Article

References (52)

1. Fredrickson D.S., P.H. Altrocchi, L.V Avioli, D.S. Goodman, and H.C. Goodman. 1961. Tangier disease - Combined clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 55:1016-1021.
2. Assmann, G., A. von Eckardstein, and H.B. Brewer, Jr. 1995. Familial HDL deficiency. Tangier disease. In The Metabolic Basis of Inherited Disease. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Book Co., New York. 2053-2072.
3. Schaefer, E.J., C.B. Blum, R.I. Levy, L.L. Jenkins, P. Alaupovic, D.M. Foster, and H.B. Brewer, Jr. 1978. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N. Engl. J. Med. 299:905-910.
4. Bojanovski, D., R.E. Gregg, L.A. Zech, M.S. Meng, C. Bishop, R. Ronan, and H.B. Brewer, Jr. 1987. In vivo metabolism of proapolipoprotein A-I in Tangier disease. J. Clin. Invest. 80:1042-1047.
5. Tangier and the amino acid sequence of the propeptide. Biochem. Biophys. Res. Commun. 113:934-940.
6. Schmitz, G., G. Assmann, H. Robenek, and B. Brennhausen. 1985. Tangier disease: a disorder of intracellular membrane traffic. Proc. Natl. Acad. Sci. USA. 82:6305-6309.
7. Schmitz, G., H. Fischer, M. Beuck, K.-P. Hoecher, and H. Robenek. 1990. Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages. Arteriosclerosis. 10:1010-1019.
8. Robenek, H., and G. Schmitz. 1991. Abnormal processing of Golgi elements and lysosomes in Tangier disease. Arterioscler. Thromb. 11:1007-1020.
9. Assmann, G., P.N. Herbert, D.S. Fredrickson, and T. Forte. 1977. Isolation and characterization of an abnormal high density lipoprotein in Tangier disease. J. Clin. Invest. 60:242-252.
10. Assmann, G., E. Smootz, K. Adler, A. Capurso, and K. Oette. 1977. The lipoprotein abnormality in Tangier disease. J. Clin. Invest. 59:565-575.
11. Assmann, G., O. Simantke, H.E. Schaefer, and E. Smootz. 1977. Characterization of high density lipoproteins in patients heterozygous for Tangier disease. J. Clin. Invest. 60:1025-1035.
12. Gheorghiu, T.H., G. Assmann, and H.E. Schaefer. 1976. Endoscopical findings in Tangier disease. Endoscopy, 9:164.
13. Schaefer, H.E., G. Assmann, and T.H. Gheorghiu. 1976. Licht- und elektronenmikroskopische Untersuchungen zur Tangier-Krankheit (sog. An-alpha-Lipoproteinämie). Verh. Dtsch. Ges. Path. 60:473.
14. Schaefer, H.E., and G. Assmann. 1979. Cholesteastosis naevi naevocellularis - ein bisher unbekanntes Phänomen bei der Tangier-Krankheit. Verh. Dtsch. Ges. Path. 63:708.
15. Assmann, G., A. Capurso, E. Smootz, and U. Wellner. 1978. Apoprotein A metabolism in Tangier disease. Atherosclerosis. 30:321-332.
16. Assmann, G., and E. Smootz. 1978. High density lipoprotein infusion and partial plasma exchange in Tangier disease. Eur. J. Clin. Invest. 8:131-135.
17. Walter, M., S. Kerber, C. Fechtrup, U. Seedorf, G. Breithardt, and G. Assmann. 1994. Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency. Atherosclerosis. 110:203-208.
18. Walter, M., U. Gerdes, U. Seedorf, and G. Assmann. 1994. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205:850-856.
19. Francis, G.A., R.H. Knopp, and J.F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96:78-87.
20. Rogler, G., B. Trümbach, B. Klima, K.J. Lackner, and G. Schmitz. 1995. High density lipoprotein-mediated efflux of newly synthesized cholesterol is impaired in fibroblasts from Tangier patients while membrane desorption and efflux of lysosomal cholesterol are normal. Arterioscler. Thromb. Vasc. Biol. 15: 683-690.
21. Oram, J.F., E.A. Brinton, and E.L. Bierman. 1983. Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72:1611-1621.
22. 3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 15:1975-1986.
23. Milligan, G. 1988. Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem. J. 255:1-13.
24. Pappu, A.S., and G. Hauser. 1983. Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase. Neurochem. Res. 8:1565-1575.
25. Havel, R.J., H.A. Eder, and J.H. Bragdon. 1995. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345-1353.
26. Brinton, E.A., J.F. Oram, C.-H. Chen, J.J. Albers, and E.L. Bierman. 1986. Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J. Biol. Chem. 261:495-503.
27. Chen, C., and J.J. Albers. 1982. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyl transferase activity. J. Lipid Res. 23:680-691.
28. von Eckardstein, A., H. Funke, M. Walter, K. Atland, A. Benninghoven, and G. Assmann. 1990. Structural analysis of human apolipoprotein A-I variants: amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265:8610-8617.
29. Folch, J., M. Lees, and G.H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 26:497-509.
30. Kaszkin, M., L. Seidler, R. Kast, and V. Kinzel. 1992. Epidermal-growth-factor-induced production of phosphatidylalcohols by HeLa cells and A431 cells through activation of phospholipase D. Biochem. J. 287:51-57.
31. Yavin, E. 1976. Regulation of phospholipid metabolism in differentialing cells from rat brain cerebral hemispheres in culture. J. Biol. Chem. 251: 1392-1397.
32. Heider, J.G., and R.L. Boyett. 1978. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19:514-518.
33. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
34. Heller, M. 1978. Phospholipase D. Adv. Lipid Res. 16:267-326.
35. Pai, J.-K., M.I. Siegel, R.W. Egan, and M.M. Billah. 1988. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. J. Biol. Chem. 263:12472-12477.
36. Bell, R.L., D.A. Kennerly, N. Stanford, and P.W. Majerus. 1979. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc. Natl. Acad. Sci. USA. 76:3238-3241.
37. Graham, D.L., and J.F. Oram. 1987. Identification and characterization of a high density lipoprotein-binding protein in cell membrane by ligand blotting. J. Biol. Chem. 263:19318-19323.
38. Phillips, M.C., W.J. Johnson, and G.H. Rothblat. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906:223-276.
39. Ambar, I., and S. Mordechai. 1993. Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. Eur. J. Pharmacol. 245:31-41.
40. Takuwa, N., Y. Takuwa, and H. Rasmussen. 1987. A tumour promotor, 12-O-tectradecanoylphorbol 13-acetate, increases cellular 1,2-diacylglycerol content through a mechanism other than phosphoinositide hydrolysis in Swissmouse 3T3 fibroblasts. Biochem. J. 243:647-653.
41. Neer, E.J. 1995. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:249-257.
42. 2-C10 adrenergic receptors expressed in rat 1 fibroblasts can regulate both adenylylcyclase and phospholipase D-mediated hydrolysis of phosphatidylcholine by interacting with pertussis toxin-sensitive guanine nucleotide-binding proteins. J. Biol. Chem. 267:2149-2156.
43. van Blitterswijk, W.J., H. Hilkmann, J. de Widt, and R.L. van der Bend. 1991. Phospholipid metabolism in bradykinin-stimulated human fibroblasts. J. Biol. Chem. 266:10344-10350.
44. Reinhart, W.H., U. Gössi, P. Bütikofer, P. Ott, H. Sigrist, H.-J. Schatzmann, H.U. Lutz, and W. Straub. 1989. Haemolytic anaemia in analphalipoproteinaemia (Tangier disease): Morphological, biochemical, and biophysical properties of the red blood cells. Br. J. Haematol. 72:272-277.
45. 3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler. Thromb. Vasc. Biol. 15:1369-1377.
46. Mendez, A.J., J.F. Oram, and E.L. Bierman. 1991. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266:10104-10111.
47. Billah, M.M. 1993. Phospholipase D and cell signaling. Curr. Opin. Immunol. 5:114-123.
48. Galla, H.J., and E. Sackmann. 1975. Chemically induced lipid phase separation in model membranes containing charged lipids: a spin label study. Biochim. Biophys. Acta. 401:509-529.
49. Gordon, D., and B.M. Rifkind. 1989. Current concepts: high density lipoproteins - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1315.
50. Mautner, S.L., J.A. Sanchez, D.A. Rader, G.C. Mautner, V.J. Ferrans, D.S. Fredrickson, H.B. Brewer, Jr., and W.C. Roberts. 1992. The heart in Tangier disease. Severe coronary atherosclerosis with near absence of high-density lipoprotein cholesterol. Am. J. Clin. Pathol. 98:191-198.
51. Serfaty-Lacrosniere, C., F. Civeira, A. Lanzberg, P. Isaia, J. Berg, E.D. Janus, M.P. Smith, Jr., P.H. Pritchard, J. Frohlich, R.S. Lees, G.F. Barnard, J.M. Ordovas, and E. J. Schaefer. 1994. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107:85-98.
52. Lerman, A., B.S. Edwards, J.W. Hallett, D.M. Heublein, S.M. Sandberg, and J.C. Burnett, Jr. 1991. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325:997-1001.